Home/EU PhD vacancies
About the school
Established in 1925 and boasting a rich and distinguished heritage, the School of Pharmacy aims to nurture outstanding researchers in a modern, forward-thinking and exciting place of work.
A visit to meet our internationally renowned staff and our multimillion pound facilities reveals the outstanding and wide-ranging research opportunities available at the University of Nottingham.
Our research is focused on understanding some of the most complex and challenging diseases of our time and developing treatments that are truly pioneering. We work with many of the major pharmaceutical and biotechnology companies and have had the vision to start up several successful commercial ventures, providing valuable services to the pharmaceutical industry.
Faced with exciting opportunities for new therapeutic targets and treatments that will improve the lives of millions of people, we’re proud to be at the forefront of world-changing, interdisciplinary research that’s both innovative and relevant.
Our highly respected academics work in a broad range of areas including
- drug delivery and tissue engineering
- the social aspects of medicines and health
- medicinal chemistry and structural biology
- molecular and cellular science
- nanotechnology and biophysics and surface analysis.
Working alongside the academics and research staff are some of the most talented postgraduate students in the world – the majority of whom are funded through competitive research council studentships. Every year we take on around 50 PhD students; the largest intake of any UK pharmacy school.
Connections with industry
Researchers receive funding from many of the major UK and Europe funding councils as well as from industry.
We work with many of the major pharmaceutical and biotechnology companies, including:
- 3M Healthcare
- Smith & Nephew
AstraZeneca has set up a unique major doctoral training centre in the School in conjunction with the Engineering and Physical Sciences Research Council.
Our outstanding research has led to many commercial advances, including a number of drug developments, more than two dozen filed patents, and almost 30 licensing deals and research programmes involving over 40 international pharmaceutical companies
As well as partnerships with industry, we’ve also launched several successful spin-out companies in order to commercialise services and products that have been developed in-house.